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Abstract 
Introduction: The COVID-19 pandemic has presented 
enormous challenges for dentists and patients. The risk 
of nosocomial transmission is a reality that requires the 
development of guidelines by the dental community to 
reduce the chances of infection by the new coronavirus. 
In this sense, it was necessary to implement alternative 
prophylactic techniques such as the adoption of oral 
rinses before dental care. Objective: To present the 
main considerations of clinical studies on dental care at 
COVID-19. Methods: The research was carried out 
from May 2021 to June 2021 and developed based on 
Scopus, PubMed, Science Direct, Scielo, and Google 
Scholar, following the Systematic Review-PRISMA rules. 
The quality of the studies was based on the GRADE 
instrument and the risk of bias was analyzed according 
to the Cochrane instrument. Results: One study 
showed that 0.2% chlorhexidine and 1% povidone-
iodine oral solutions are effective pre-procedural 
mouthwashes against salivary SARS-CoV-2 in dental 
treatments. It was observed in another study that the 
effect of reducing the salivary load with mouthwash 
with CPC and PI was maintained after 6 hours. PVP-I 
nasal and oral antiseptic solutions are effective in 
inactivating SARS-CoV-2 at a range of concentrations 
after exposure times of 60 seconds. There is sufficient 
in vitro evidence to support the use of antiseptics to 
potentially reduce the viral load of SARS-CoV-2. The 
effects against the new coronavirus in vivo still need 
more randomized clinical trials to prove its 
effectiveness. Conclusion: ACE2 receptors are highly 
expressed in the oral cavity, therefore, this could be a 
potential high-risk route for SARS-CoV-2 infection. The 
virus can be detected in saliva even before the  
 
appearance of symptoms of COVID-19. In this regard, 
randomized clinical studies have shown that some pre-
procedure oral mouthwashes are effective against 
salivary SARS-CoV-2 in dental treatments. In addition, 
the American Academy of Implant Dentistry (AAID) 
reported on how COVID-19 impacts dental care through 
guidelines for general dentistry. 
Keywords: Dentistry. Dental care. Mouthwashes. 
Prophylaxis. Pandemic. COVID-19. Guidelines. 
 
Introduction 
The COVID-19 pandemic has presented enormous 
challenges for dentists and patients [1]. The risk of 
nosocomial transmission is a reality that requires the 
development of guidelines by the dental community to 
reduce the chances of infection by the new coronavirus. 
Thus, credible recommendations are needed and 
research gaps could be filled by soliciting the opinion of 
international frontline experts [2]. 
In this context, the transmission risk for non-
aerosol procedures in dental offices was considered low 
or neutral by approximately 55% of specialists, while for 
aerosol-generating procedures, the vast majority (93%) 
agreed that the risk was high [2]. Despite this, the 
current pandemic is an opportunity for constructive 
change, to improve hygiene techniques and more 
patient-centered care [3]. It is the right time to redefine 
and rethink the role of healthcare professionals. The 
"3R" principle, (R)edefinition, (R)econsideration, and 
(R)eflections, addresses these challenges well in the 
dental sector [4]. 
In this aspect, dental care is a crucial element in 






















MedNEXT J Med Health Sci (2021) Page 2 of 6 




studies have evaluated the efficacy of pre-dental oral 
rinses in reducing the viral load of salivary SARS-CoV-2 
[6,7]. Even though relevant key expressions such as 
screening, prioritization, commitment, and difficult 
decision-making have become a daily reality in this time 
of the pandemic, these actions can bring "added value" 
and improve our service, especially with 
teleconsultations. Also, because the impact of COVID-
19 on well-being and mental health appears to be 
significant, dental services will need to be able to 
provide psychological counseling [8,9-12]. 
In this sense, it was necessary to implement 
alternative techniques for the treatment of phobic 
patients or patients with behavioral disorders, such as 
gradual exposure, hypnotherapy, behavioral 
management, professional cognitive-behavioral therapy 
(CBT), the use of virtual glasses for distraction, 
desensitization methods, etc. [13-15]. Thus, the 
recently implemented strict cross-infection control 
measures and awareness of the transmission of 
infectious diseases have positively influenced the 
management of dental services. 
In this scenario, the overall impact of SARS-CoV-2 
on general health is considered to be much more 
profound, with significant effects across multiple 
systems and functions [16-20]. Thus, after the 
pandemic, dental teams must be well prepared to deal 
with the increasing number of patients with unresolved 
medical and dental problems or unfinished courses of 
treatment [21]. 
Therefore, the present study presented the main 





This was followed by a systematic literature review 
model, according to the PRISMA rules [22]. 
 
Data sources and research strategy 
The search strategies for this review were based 
on the descriptors: “Dentistry. Dental care. 
Mouthwashes. Prophylaxis. Pandemic. COVID-19. 
Guidelines". The research was carried out from June 
2021 to October 2021 and developed based on Google 
Scholar, Scopus, PubMed, Scielo, and Cochrane Library. 
Also, a combination of the keywords with the Booleans 
"OR", "AND", and the operator "NOT" were used to 
target the scientific articles of interest. 
 
Study quality and risk of bias 
The quality of the studies was based on the GRADE 
instrument [23], with guidelines, randomized controlled 
clinical studies, prospective controlled clinical studies, 
and studies of systematic review and meta-analysis 
listed as the studies with the greatest scientific 
evidence. The risk of bias was analyzed according to the 
Cochrane instrument [24]. 
 
Results and Discussion 
After the selectivity of articles and literary findings, 
255 studies were analyzed, with only 26 medium and 
high-quality studies selected, according to GRADE rules, 
and with risks of bias that do not compromise scientific 
development, based on the Cochrane instrument 
(Figure 1). After analyzing the major clinical studies on 
the safety of dental procedures in the COVID-19 
pandemic, it was observed that many state or local 
governments classified dental treatments as not 
essential to preventing infections as much as possible. 
Dentists were instructed to only perform procedures 
designated as emergencies. In this sense, dentistry has 
been advancing strongly in improving oral health 
through the prevention of dental emergencies [25,26]. 
In this regard, a randomized controlled clinical trial 
evaluated the efficacy of 2 pre-procedure types of 
mouthwash in reducing the viral load of salivary SARS-
CoV-2 and compared the results of mouthwashes with a 
control group. The study group consisted of COVID-19 
positive patients confirmed in the laboratory using 
nasopharyngeal swabs. Participants were divided into 3 
groups. For 30 seconds, the control group rinsed their 
mouths with distilled water, another group rinsed their 
mouths with 0.2% Chlorhexidine, and the Povidone-
iodine group gargled with 1% Povidone-iodine. Saliva 
samples were collected before and 5 minutes after 
mouth rinsing. SARS-CoV-2 RRT-PCR was then 
performed for each sample. Sixty-one compliant 
participants (36 women and 25 men) with a mean age 
of 45.3 ± 16.7 years were enrolled. A significant 
difference was observed between the delta Ct of the 
distilled water wash and each of the 2 solutions of 0.2% 
Chlorhexidine and 1% Povidone-iodine. No significant 
difference was found between the delta Ct of patients 
using 0.2% chlorhexidine and 1% povidone-iodine 
solutions. A significant difference in the mean Ct value 
was found between paired samples in the Chlorhexidine 
group (n = 27) and also in the Povidone-iodine group (n 
= 25). In contrast, no significant difference existed 
before and after the experiment in the control group (n 
= 9). Therefore, oral solutions of 0.2% chlorhexidine 
and 1% povidone-iodine are pre-procedural 
mouthwashes effective against salivary SARS-CoV-2 in 
dental treatments [6]. 
Yet another randomized controlled clinical trial 
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evaluated the efficacy of three commercial oral types of 
mouthwash such as povidone-iodine (PI), chlorhexidine 
gluconate (CHX), and cetylpyridinium chloride (CPC) in 
reducing salivary viral load SARS-CoV-2 in patients with 
COVID-19 compared to water. A total of 36 SARS-CoV-
2 positive patients were recruited, of which 16 patients 
were randomly assigned to four groups-PI groups (n = 
4), CHX group (n = 6), CPC group (n = 4 ), and water 
as a control group (n = 2). Saliva samples were collected 
from all patients at baseline and 5 min, 3 h, and 6 h 
after application of mouthwashes and water. The 
samples were submitted to SARS-CoV-2 RT-PCR 
analysis. As a result, it was observed that the effect of 
reducing salivary load with oral rinsing with CPC and PI 
was maintained after 6 hours [7]. 
Also, a study evaluated nasal and oral antiseptic 
formulations of PVP-I against SARS-CoV-2. Nasal 
antiseptic formulations of povidone-iodine and 
antiseptic oral rinse formulations of PVP-I at 
concentrations from 1% to 5%, as well as controls, were 
studied. Nasal and oral antiseptic solutions of PVP-I are 
effective in inactivating SARS-CoV-2 at a range of 
concentrations after exposure times of 60 seconds [27]. 
In this scenario, it is noteworthy that ACE2 
receptors are highly expressed in the oral cavity, 
therefore, this may be a potentially high-risk route for 
SARS-CoV-2 infection. In addition, the virus can be 
detected in saliva even before the appearance of 
symptoms of COVID-19, with the consequent risk of 
virus transmission. Lowering the oral viral load may lead 
to a lower risk of transmission through salivary droplets 
or aerosols. Thus, a review study evaluated the 
available evidence testing the in vitro and in vivo effects 
of oral antiseptics to inactivate or eradicate 
coronaviruses. It is sufficient in vitro evidence to 
support the use of antiseptics to potentially reduce the 
viral load of SARS-CoV-2. The effects against the new 
coronavirus in vivo still need more randomized clinical 
trials to prove its efficacy [28]. 
In this regard, the American Academy of Implant 
Dentistry (AAID) reported how COVID-19 impacts dental 
care through guidelines for dentistry in general. Thus, 
Table 1 below highlights the main issues [29]. 
Besides, European guidelines and expert opinion 
have shown the control and prevention of infections in 
dentistry during the pandemic. The dynamics of the 


































 Additional records (n = 40) 
Total = 255 Records after duplicates 
removed (n = 98) 
Articles screened 
(n = 157) 
Excluded (Not GRADE) 
(n = 103) 
Full-text articles assessed  
(n = 54) 
Studies included in 
systematic review 
(n = 26) 
Excluded (BIAS) 
(n = 28) 
Qualitative synthesis 
(n = 26) 
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pandemic had an impact on rapidly published and 
frequently updated national guidelines in Europe. As the 
guidelines were not based on solid evidence, they were 
supplemented by expert opinion on the control and 
prevention of infections in dentistry. Dental care should 
be guaranteed during the pandemic, but in case of 
suspected or confirmed COVID-19 disease, treatment 
should be delayed if possible [25]. 
 
Table 1. Issues about dental care in the COVID-19 
pandemic [29]. 
 
✓ What constitutes a dental implant-related emergency? 
✓ How should patients be screened and screened? 
✓ What personal protective equipment is needed? 
✓ How should operators be equipped? 
✓ What equipment should be used? 
✓ What, when, and how can procedures be performed? 
 
In addition, remote screening and patient-related 
measures have been recommended as the most 
effective in reducing SARS-CoV-2 transmission. The 
type of personal protective equipment provided by the 
dental team must be appropriate to the procedure and 
the risk of infection. It is important to continually update 
dental guidelines, considering the evolution of the 
pandemic and the new scientific evidence available [3]. 
Thus, a study assessed the opinion of European 
experts on the control and prevention of infections in 
dentistry during the second wave of the pandemic. A 
total of 26 experts participated in the survey. The 
overall risk of transmission in dental settings was scored 
lower compared to the initial survey, although the risk 
associated with aerosol-generating procedures (AGP) 
was still high. The use of PPE was less frequently 
recommended for non-AGP, while most experts still 
recommended FFP2 / FFP3 masks (80.8%), face shields 
or goggles (88.5%), lab coats (61.5 %), and caps 
(57.7%) for AGP. Most specialists also considered the 
mouthwash to be relevant (73.1%) and reported using 
it before treatment (76.9%). No uniform opinion was 
found regarding the relevance of the COVID-19 test for 
staff and patients [25]. 
Also, a study gathered experiences and 
recommendations from frontline clinical experts on 
critical aspects of providing dental care during the 
pandemic. The risk of SARS-CoV-2 transmission in 
dental settings for aerosol-generating procedures was 
considered high. For non-aerosol procedures and 
aerosol generators, more than 80% of experts 
recommended face shields and caps for each treatment. 
For aerosol generation procedures, additional measures 
(FFP2/FFP3 masks and aprons) were suggested by the 
vast majority of experts. Therefore, limiting aerosol 
generation procedures along with the use of adequate 
personal protective equipment was considered crucial to 
protect oral health professionals and patients [3]. 
 
Conclusion 
ACE2 receptors are highly expressed in the oral 
cavity, therefore, this may be a potential high-risk route 
for SARS-CoV-2 infection. The virus can be detected in 
saliva even before the appearance of symptoms of 
COVID-19. In this regard, randomized clinical studies 
have shown that some pre-procedure oral mouthwashes 
are effective against salivary SARS-CoV-2 in dental 
treatments. In addition, the American Academy of 
Implant Dentistry (AAID) reported on how COVID-19 
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